Viewing Study NCT00368147



Ignite Creation Date: 2024-05-05 @ 5:00 PM
Last Modification Date: 2024-10-26 @ 9:27 AM
Study NCT ID: NCT00368147
Status: COMPLETED
Last Update Posted: 2023-11-13
First Post: 2006-08-23

Brief Title: Access Creation for Hemodialysis Association With Structural Changes of the Heart
Sponsor: Ottawa Hospital Research Institute
Organization: Ottawa Hospital Research Institute

Study Overview

Official Title: Access Creation for Hemodialysis Potential Contribution to Left Ventricular Remodelling
Status: COMPLETED
Status Verified Date: 2023-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to determine if the creation of a fistula or a graft plays a role in the development of heart disease for patients undergoing hemodialysis
Detailed Description: Patients with end stage renal disease are at 18-20 times greater risk of dying from cardiovascular disease as the general population Both traditional and non-traditional cardiovascular risk factors are thought to be important Of the non-tradtional cardiovascular risk factors creation of an arteriovenous fistula or graft for the purposes of a blood access for hemodialysis may contribute to an elevation in BNP and left ventricular hypertrophy - both factors that have been associated with an increased risk of mortality Prior to access creation and at one month and one year post access creation - samples for BNP will be collected Prior to access creation and at one year post access creation - echocardiography will be performed

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None